Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis

Clinical trial NCT05521022 · UNKNOWN

Trial details

NCT number: NCT05521022
Sponsor: Attralus, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Amyloidosis; Systemic

Start date: 2022-09-01
Primary completion: 2025-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.